An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED)

NCT07462130 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Eye Disease

Interventions

DRUG: NTB003
DRUG: NTB003
DRUG: NTB003
DRUG: NTB003 and Placebo

Sponsor

Nanjing Chia-tai Tianqing Pharmaceutical